Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis

Gadducci, 1996, Uterine leiomyosarcoma: analysis of treatment failures and survival, Gynecol Oncol., 62, 25, 10.1006/gyno.1996.0185

Giuntoli, 2004, Uterine leiomyosarcoma: present management, Curr Opin Oncol., 16, 324, 10.1097/01.cco.0000127721.55676.f6

McCluggage, 2003, Mixed epithelial and mesenchymal tumours

Bell, 1994, Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases, Am J Surg Pathol., 18, 535, 10.1097/00000478-199406000-00001

Hendrickson, 2003, Mesenchymal tumours and related lesions

D'Angelo, 2009, Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system, Hum Pathol, 40, 1571, 10.1016/j.humpath.2009.03.018

Guntupalli, 2009, Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis, Gynecol Oncol., 113, 324, 10.1016/j.ygyno.2009.02.020

Ip, 2009, Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP): a clinicopathologic analysis of 16 cases, Am J Surg Pathol, 33, 992, 10.1097/PAS.0b013e3181a02d1c

Abeler, 2009, Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients, Histopathology., 54, 355, 10.1111/j.1365-2559.2009.03231.x

Denschlag, 2007, Prognostic factors and outcome in women with uterine sarcoma, Eur J Surg Oncol., 33, 91, 10.1016/j.ejso.2006.11.012

Giuntoli, 2003, Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy, Gynecol Oncol., 89, 460, 10.1016/S0090-8258(03)00137-9

Koivisto-Korander, 2008, Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001, Gynecol Oncol., 111, 74, 10.1016/j.ygyno.2008.06.002

Wang, 2007, Histopathologic prognostic factors in stage I uterine leiomyosarcomas (Ut-LMS): a clinicopathologic study of 28 cases, Mod Path, 217A

2009, FIGO staging for uterine sarcomas, Int J Gynaecol Obstet, 104, 179, 10.1016/j.ijgo.2008.12.009

Akhan, 2005, The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas, A clinicopathologic study. Gynecol Oncol., 99, 36, 10.1016/j.ygyno.2005.05.019

Atkins, 2008, The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors, Am J Surg Pathol., 32, 98, 10.1097/PAS.0b013e3181574d1e

Bodner, 2004, Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma, J Soc Gynecol Investig., 11, 187, 10.1016/j.jsgi.2003.10.003

Bodner-Adler, 2005, Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis, Gynecol Oncol., 96, 62, 10.1016/j.ygyno.2004.09.026

Chen, 2008, Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors, Int J Gynecol Pathol., 27, 326, 10.1097/PGP.0b013e31815ea7f5

Mittal, 2001, Demopoulos RI.MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors, Hum Pathol., 32, 984, 10.1053/hupa.2001.27113

O'Neill, 2007, Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential, Histopathology., 50, 851, 10.1111/j.1365-2559.2007.02699.x

Zhai, 1999, Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas, Int J Gynecol Pathol., 18, 20, 10.1097/00004347-199901000-00004

Bissell, 2001, Putting tumours in context, Nat Rev Cancer, 1, 46, 10.1038/35094059

Elenbaas, 2001, Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation, Exp Cell Res, 264, 169, 10.1006/excr.2000.5133

Espinosa, 2009, Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma, Am J Pathol., 174, 2347, 10.2353/ajpath.2009.081037

Nocito, 2001, Tissue microarrays (TMAs) for high-throughput molecular pathology research, Int J Cancer., 94, 1, 10.1002/ijc.1385

Liu, 2005, TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays, Mod Pathol, 18, 1641, 10.1038/modpathol.3800491

Liu, 2002, Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays, Am J Pathol, 161, 1557, 10.1016/S0002-9440(10)64434-3

Kapp, 2008, Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy, Cancer, 112, 820, 10.1002/cncr.23245

Mayerhofer, 1999, Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases, Gynecol Oncol., 74, 196, 10.1006/gyno.1999.5436

D'Angelo, 2010, Uterine Sarcomas, A review. Gynecol Oncol., 116, 131, 10.1016/j.ygyno.2009.09.023

Evans, 1988, Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases with emphasis on diagnostic criteria and prognostic factors, Cancer, 62, 2239, 10.1002/1097-0142(19881115)62:10<2239::AID-CNCR2820621028>3.0.CO;2-Y

Larson, 1990, Prognostic factors in uterine leiomyosarcoma: a clinicopathologic study of 143 cases. The Radiumhemmet series, 1936–1981, Acta Oncol, 29, 185, 10.3109/02841869009126543

Nordal, 1995, The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma, Acta Oncol, 34, 797, 10.3109/02841869509127189

Garg, 2010, Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population based study, Int J Gynecol Cancer, 20, 1201, 10.1111/IGC.0b013e3181e9d0ba

Major, 1993, Prognostic factors in early stage uterine sarcoma: a Gynecologic Oncology Group study, Cancer, 71, 1702, 10.1002/cncr.2820710440

Pautier, 2000, Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma, Cancer., 88, 1425, 10.1002/(SICI)1097-0142(20000315)88:6<1425::AID-CNCR21>3.0.CO;2-3

Zhai, 1999, Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus, Br J Cancer., 80, 1658, 10.1038/sj.bjc.6690578